| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Chief Legal & Admin Officer | Common Stock | 89,322 | $1,137,962 | $12.74 | 23 Dec 2025 | Direct |
| OptimizeRx Corp | Chief Legal & Admin Officer | Restricted Stock Units | 3,928 | $0 | $10.70 | 19 Dec 2025 | Direct |
| OptimizeRx Corp | Chief Legal & Admin Officer | Stock Option | 35,156 | 21 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | 23 Dec 2025 | 1 | -$51,610 | 4 | Chief Legal & Admin Officer | 23 Dec 2025, 16:53 |
| OPRX | OptimizeRx Corp | 19 Dec 2025 | 3 | -$15,577 | 4 | Chief Legal & Admin Officer | 22 Dec 2025, 10:09 |
| OPRX | OptimizeRx Corp | 03 Oct 2025 | 3 | -$36,600 | 4 | Chief Legal & Admin Officer | 07 Oct 2025, 18:46 |
| OPRX | OptimizeRx Corp | 21 Aug 2025 | 2 | $0 | 4 | Chief Legal & Admin Officer | 25 Aug 2025, 16:29 |
| OPRX | OptimizeRx Corp | 01 Mar 2025 | 3 | -$1,388 | 4 | Chief Legal Officer & CHRO | 04 Mar 2025, 09:16 |
| OPRX | OptimizeRx Corp | 15 Feb 2025 | 1 | -$9,821 | 4 | Chief Legal Officer & CHRO | 20 Feb 2025, 13:38 |
| OPRX | OptimizeRx Corp | 11 Feb 2025 | 3 | -$7,762 | 4 | General Counsel and CCO | 13 Feb 2025, 15:58 |
| OPRX | OptimizeRx Corp | 23 Dec 2024 | 2 | $0 | 4 | General Counsel and CCO | 27 Dec 2024, 14:08 |
| OPRX | OptimizeRx Corp | 19 Dec 2024 | 3 | -$5,477 | 4 | General Counsel and CCO | 20 Dec 2024, 19:48 |
| OPRX | OptimizeRx Corp | 08 Nov 2024 | 3 | -$3,285 | 4 | General Counsel and CCO | 12 Nov 2024, 09:37 |
| OPRX | OptimizeRx Corp | 03 Oct 2024 | 3 | -$15,284 | 4 | General Counsel and CCO | 07 Oct 2024, 21:26 |
| OPRX | OptimizeRx Corp | 01 Mar 2024 | 3 | -$4,275 | 4 | General Counsel and CCO | 06 Mar 2024, 16:19 |
| OPRX | OptimizeRx Corp | 15 Feb 2024 | 1 | $0 | 4 | General Counsel and CCO | 24 Apr 2024, 10:17 |
| OPRX | OptimizeRx Corp | 11 Feb 2024 | 3 | -$21,331 | 4 | General Counsel and CCO | 13 Feb 2024, 18:16 |
| OPRX | OptimizeRx Corp | 09 Jan 2024 | 1 | -$60,751 | 4 | General Counsel and CCO | 11 Jan 2024, 17:06 |
| OPRX | OptimizeRx Corp | 19 Dec 2023 | 2 | $0 | 4 | General Counsel and CCO | 21 Feb 2024, 18:23 |
| OPRX | OptimizeRx Corp | 08 Nov 2023 | 3 | -$4,826 | 4 | General Counsel and CCO | 13 Nov 2023, 14:32 |
| OPRX | OptimizeRx Corp | 03 Oct 2023 | 3 | -$13,781 | 4 | General Counsel and CCO | 06 Oct 2023, 14:47 |
| OPRX | OptimizeRx Corp | 01 Mar 2023 | 3 | -$4,853 | 4 | General Counsel and CCO | 03 Mar 2023, 14:41 |
| OPRX | OptimizeRx Corp | 11 Feb 2023 | 3 | -$24,657 | 4 | General Counsel and CCO | 14 Feb 2023, 10:32 |
| OPRX | OptimizeRx Corp | 08 Nov 2022 | 3 | -$10,309 | 4 | General Counsel and CCO | 10 Nov 2022, 14:29 |
| OPRX | OptimizeRx Corp | 03 Oct 2022 | 2 | $0 | 4 | General Counsel and CCO | 05 Oct 2022, 13:15 |
| OPRX | OptimizeRx Corp | 26 Aug 2022 | 1 | +$15,750 | 4 | General Counsel and CCO | 30 Aug 2022, 16:45 |
| OPRX | OptimizeRx Corp | 01 Mar 2022 | 2 | $0 | 4 | General Counsel and CCO | 03 Mar 2022, 15:45 |
| OPRX | OptimizeRx Corp | 11 Feb 2022 | 2 | $0 | 4 | General Counsel and CCO | 15 Feb 2022, 15:45 |
| OPRX | OptimizeRx Corp | 08 Nov 2021 | 2 | $0 | 4 | General Counsel and CCO | 10 Nov 2021, 15:45 |